卵母细胞冷冻保存用于供卵IVF与计划性冻卵的循证结局指南
美国生殖医学会基于1986至2018年发表的系统综述、荟萃分析、随机对照试验及前瞻性和回顾性比较观察性研究,经共识制定循证推荐。共纳入30项相关研究。结论指出,计划性冻卵后的活产率证据不足;有限数据显示年轻女性计划性冻卵的持续妊娠率和活产率优于年长女性。
要点
- 计划性冻卵后的活产率目前证据不足,无法准确预测。
- 有限数据显示,计划性冻卵时年龄较轻者的持续妊娠率和活产率优于年龄较大者。
- 冷冻与新鲜供卵每移植周期的妊娠率无显著差异,但玻璃化冷冻与新鲜供卵活产率是否相同证据不足。
核心结论
- 计划性冻卵后的活产率证据不足,无法预测。
- 有限数据显示,年轻女性计划性冻卵的持续妊娠率和活产率优于年长女性。
- 冷冻与新鲜供卵卵母细胞每移植周期的妊娠率无显著差异,但玻璃化冷冻与新鲜供卵活产率是否相同证据不足。
- 冷冻卵母细胞与新鲜卵母细胞的新生儿结局似乎相似。
研究设计与样本
- 美国生殖医学会进行文献检索,纳入1986至2018年发表的系统综述、荟萃分析、随机对照试验及前瞻性和回顾性比较观察性研究。
- 由美国生殖医学会实践委员会与专家工作组基于现有证据经共识制定循证指南推荐。
- 文献检索共纳入30项相关研究以构建本指南的证据基础。
主要发现
- 文献检索共识别30项相关研究。
- 有限数据显示,计划性冻卵时年龄较轻者的持续妊娠率和活产率优于年龄较大者。
- 冷冻与新鲜供卵卵母细胞每移植周期的妊娠率无显著差异。
- 冷冻卵母细胞与新鲜卵母细胞的新生儿结局似乎相似。
关键数值与推荐
- 推荐涵盖预测计划性冻卵后活产可能性、不孕女性自体冻卵及供卵冻卵,以及可能影响活产率的因素。
- 推荐涉及自体或供卵情况下使用新鲜与冷冻卵母细胞后的新生儿结局。
- 玻璃化冷冻与新鲜供卵卵母细胞活产率是否相同证据不足。
临床怎么用
- 咨询计划性冻卵时应说明活产率证据不足,避免给出确定性预测。
- 可告知有限数据显示较年轻时冻卵的持续妊娠率和活产率更优。
- 冷冻与新鲜供卵卵母细胞每移植周期妊娠率无显著差异,新生儿结局似乎相似。
- 玻璃化冷冻与新鲜供卵活产率是否等同尚需进一步研究。
局限性
- 计划性冻卵后活产率的证据不足。
- 玻璃化冷冻与新鲜供卵卵母细胞活产率是否相同证据不足。
- 需未来开展比较累积活产率的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide evidence-based recommendations to practicing physicians and others regarding the efficacy of oocyte cryopreservation (OC) for donor oocyte in vitro fertilization and planned OC. METHODS: The American Society for Reproductive Medicine conducted a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 1986 to 2018. The American Society for Reproductive Medicine Practice Committee and a task force of experts used available evidence and through consensus developed evidence-based guideline recommendations. MAIN OUTCOME MEASURE(S): Outcomes of interest included live birth rate, clinical pregnancy rate, obstetrical and neonatal outcomes, and factors predicting reproductive outcomes. RESULT(S): The literature search identified 30 relevant studies to inform the evidence base for this guideline. RECOMMENDATION(S): Evidence-based recommendations were developed for predicting the likelihood of live births after planned OC, autologous OC in infertile women, and donor OC, as well as factors that may impact live birth rates. Recommendations were developed regarding neonatal outcomes after using fresh vs. cryopreserved oocytes in cases of autologous or donor oocytes. CONCLUSION(S): There is insufficient evidence to predict live birth rates after planned OC. On the basis of limited data, ongoing and live birth rates appear to be improved for women who undergo planned OC at a younger vs. older age. Although there are no significant differences in per transfer pregnancy rates with cryopreserved vs. fresh donor oocytes, there is insufficient evidence that the live birth rate is the same with vitrified vs. fresh donor oocytes. Neonatal outcomes appear similar with cryopreserved oocytes compared with fresh oocytes. Future studies that compare cumulative live birth rates are needed.
引用
- Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline. Fertil Steril. 2021. PMID: 34148587. doi:10.1016/j.fertnstert.2021.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。